Analysts Set Transcat, Inc. (NASDAQ:TRNS) PT at $111.50

Transcat, Inc. (NASDAQ:TRNS) has been assigned a consensus recommendation of “Hold” from the five research firms that are covering the firm, MarketBeat.com reports. Three research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $111.50.

A number of research analysts have recently weighed in on the stock. HC Wainwright dropped their price objective on shares of Transcat from $126.00 to $106.00 and set a “buy” rating for the company in a research note on Wednesday, January 29th. Northland Securities reissued a “market perform” rating and set a $85.00 price target (down previously from $110.00) on shares of Transcat in a research report on Wednesday, January 29th. Oppenheimer downgraded Transcat from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 29th. Finally, StockNews.com cut Transcat from a “hold” rating to a “sell” rating in a research report on Wednesday, February 5th.

Transcat Stock Performance

Shares of TRNS stock opened at $84.59 on Friday. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.98 and a current ratio of 2.42. The stock has a market cap of $787.45 million, a PE ratio of 45.72 and a beta of 0.67. Transcat has a 1 year low of $67.56 and a 1 year high of $147.12. The stock has a fifty day moving average price of $76.97 and a 200 day moving average price of $95.97.

Transcat (NASDAQ:TRNS) last released its quarterly earnings data on Monday, January 27th. The scientific and technical instruments company reported $0.45 EPS for the quarter, topping the consensus estimate of $0.38 by $0.07. Transcat had a net margin of 6.22% and a return on equity of 7.23%. During the same period last year, the firm posted $0.56 EPS. Sell-side analysts forecast that Transcat will post 2.3 earnings per share for the current fiscal year.

Insider Activity at Transcat

In related news, Director Craig D. Cairns acquired 1,200 shares of the company’s stock in a transaction dated Friday, January 31st. The stock was bought at an average price of $77.02 per share, with a total value of $92,424.00. Following the purchase, the director now directly owns 1,910 shares in the company, valued at $147,108.20. The trade was a 169.01 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Insiders own 2.30% of the company’s stock.

Institutional Investors Weigh In On Transcat

A number of institutional investors have recently bought and sold shares of TRNS. Captrust Financial Advisors acquired a new position in shares of Transcat in the 3rd quarter valued at $201,000. State Street Corp raised its position in shares of Transcat by 8.1% in the 3rd quarter. State Street Corp now owns 207,230 shares of the scientific and technical instruments company’s stock worth $25,027,000 after buying an additional 15,514 shares during the period. Barclays PLC boosted its holdings in Transcat by 393.0% in the third quarter. Barclays PLC now owns 15,130 shares of the scientific and technical instruments company’s stock valued at $1,826,000 after acquiring an additional 12,061 shares during the last quarter. Geode Capital Management LLC grew its position in Transcat by 5.4% during the third quarter. Geode Capital Management LLC now owns 217,473 shares of the scientific and technical instruments company’s stock valued at $26,269,000 after acquiring an additional 11,106 shares during the period. Finally, Virtu Financial LLC increased its stake in Transcat by 127.0% during the third quarter. Virtu Financial LLC now owns 4,136 shares of the scientific and technical instruments company’s stock worth $499,000 after acquiring an additional 2,314 shares during the last quarter. 98.34% of the stock is currently owned by hedge funds and other institutional investors.

About Transcat

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.